OMEGA 3 - EPA +
For emotional well-being
Titrated to 39% in EPA
28,80 €
Special offer
Expiration date (End Of): 07/2023 |
Lot: D15092 | Ref. CL10
1 unit
3 + 1 free
Buy OMEGA 3 - EPA +
500 mg / 120 capsules
Add to basketThis product allows you to accumulate 28 loyalty points. 28 points = 1,68€.
Ingredients: OMEGA 3 - EPA +
Consulting batch information
Consulting batch information†N/A: Not applicable
Other ingredients:
Antioxidant (E392): extracts of rosemary, antioxidant (E306): tocopherol-rich extract. Capsule: fish gelatin, humectant (E422): glycerol.
Food allergens:
Do not consume if allergic to fish. Does not contain GMOs.
Description: OMEGA 3 - EPA +
Health claims
Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) contribute to the normal function of the heart.
The omega oils in our oils are certified as not derived from salmon and have an unbeatably high purity rate.
Clinical trials have shown the incomparable contribution of food supplements of Omega 3 in case of depression or certain mental problems.
It has been found that these illnesses are accompanied by an increase in the levels of arachidonic acid (AA) in the brain, a substance which comes from an excess of Omega 6.
However, one of the constituants of Omega 3 acids, EPA (eicosapentaenoic acid) is able to counteract production of AA. Which just shows the benefit of Omega 3 high in EPA as a supplement for our emotional well-being !
Its very high EPA content makes it an exceptional product in the field of emotional well-being and depression.
OMEGA 3 - EPA +: Detailed information
The omega 3 fatty acids are the question of the moment. However, few are the products that satisfy the quality and efficiency criteria one could expect.
60 % of the brain mass is made of fatty acids. Among them, the omega 3, who in addition to their benefits for the heart, the joints, the skin, etc, are internal components essential for the brain cell membranes. As a matter of fact, they are namely involved in neurotransmission and the receptive brain functions.
We all have an emotional brain and a cognitive brain, the areas of which are separately distributed inside the organ. Now, facing and managing emotional stress requires a particular good balance between omega 3 and omega 6 polyunsaturated fatty acids. But, so that the emotional areas of the brain can function correctly, they must be provided an EPA complement, which is indeed the natural component of omega 3 that inhibits the production of arachidonic acid.
However, in order not to reduce the production of arachidonic acid (AA) for too long, it is advised to return to using omega 3, the EPA and DHA contents of which match the one found naturally (about 3 to 2).
Use: OMEGA 3 - EPA + Consulting batch information
Consulting batch informationDIRECTIONS:
4 capsules per day divided into two doses with a glass of water, at mealtimes.
WARNINGS:
Vitamin deposits (vitamin E) may occur; this natural phenomenon does not affect product quality. Not recommended for pregnant or lactating women. Do not exceed the recommended daily dose.
ADVICES:
Does not replace a varied and balanced diet and a healthy lifestyle. If you are undergoing medical treatment, seek your therapist's advice. For adult use only. Keep out of reach of young children.
STORAGE INSTRUCTIONS:
Store in a cool dry place away from sunlight.
Quality: OMEGA 3 - EPA + Consulting batch information
Consulting batch informationPRODUCT NAME
OMEGA 3 - EPA +REFERENCE
CL10QUANTITY
120 capsulesBATCH NUMBER
D15092EXPIRATION DATE
2023/07MADE
In FranceSERVINGS PER CONTAINER
30 servingsFABRICATION AND GUARANTEE:
This food supplement is manufactured in accordance with GMPs according to current pharmaceutical standards (GMPs are the Good Manufacturing Practices of the European Pharmaceutical Industry).
The active principle content is guaranteed through regular tests.
CHARACTERISTICS:
WITHOUT BPA
NO OMG
WITHOUT LACTOSE
PRODUCT ANALYSIS:
ORGANOLEPTIC QUALITY
SPECIFICATIONS
RESULTS
MICROBIOLOGICAL QUALITY
SPECIFICATIONS
RESULTS
PRODUCT REGISTRATION:
HEAD OF THE QUALITY DEPARTMENT
Certificate issue date: 2021/07/20
